UK Interdisciplinary Breast Cancer Symposium – ICC in Birmingham 22-23rd January 2024

Dear Colleagues

The next UK Interdisciplinary Breast Cancer Symposium is due to take place at the ICC in Birmingham 22-23rd January 2024.

This is the 4th Meeting of UKIBCS, and the previous meetings have been very successful bringing together oncologists, surgeons, radiologists, pathologists, scientists and others involved in breast cancer research and management. Further details of the programme and how to register can be found on:

www.ukibcs.org

The programme has been put together to address wide-ranging issues in breast cancer research and management with renowned speakers from the UK, Europe and USA.

Abstracts can be submitted for poster presentations and prizes will be given for the best abstracts.

It would be great if as many pharmacists as can attend as this is the major multidisciplinary breast cancer meeting in the UK. Please forward to your colleagues in your hospital

 

Professor Andreas Makris

Chairman of UKIBCS

 

Consultant Clinical Oncologist
Mount Vernon Cancer Centre
Northwood
Middlesex HA6 2RN
UK

Email: [email protected]

Latest News

By BOPA Executive Committee on 10th August 2026

Highlights of CAPhO Conference 2026 Webinar

Participants are invited to participate in the Highlights of CAPhO Conference 2026 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO). Taking place on Wednesday, August 19, 2026 at 08:00 PT,…

Read article
By BOPA Executive Committee on 10th August 2026

BOPA 2026 Executive Committee Election – Its time to cast your vote!

Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.  Summary of nominations: In 2026 we received 9 nominations for 6…

Read article
By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article